Product Description: Arylomycin A2, an antibiotic (Antibiotic), is a lipopeptide type I signal peptidase (SPase I) inhibitor. Arylomycin A2 has antibacterial effects[1].
Applications: COVID-19-immunoregulation
Formula: C42H60N6O11
References: [1]Mark Paetzel, et al. Crystallographic and biophysical analysis of a bacterial signal peptidase in complex with a lipopeptide-based inhibitor. J Biol Chem. 2004 Jul 16;279(29):30781-90. /[2]Katrijn Bockstael, et al. Evaluation of the type I signal peptidase as antibacterial target for biofilm-associated infections of Staphylococcus epidermidis. Microbiology (Reading). 2009 Nov;155(Pt 11):3719-3729.
CAS Number: 459844-20-3
Molecular Weight: 824.96
Research Area: Infection
Solubility: 10 mM in DMSO
Target: Antibiotic;Bacterial